Aztiq Fund is a long-term investor fund, based in Iceland, focused on real-estate, pharmaceuticals, arts & culture, and numerous community projects in Iceland and internationally.
The fund’s shareholder base consists of individual investors, as well as large international investment funds.
Aztiq’s largest assets are pharmaceutical companies Alvogen and Alvotech and the real estate company Saemundur. The fund is in the process of constructing a high-tech biologic centre in the UI (University of Iceland) Science Park in Vatnsmyri, Reykjavik, which will double the size of the fund’s pharmaceutical facilities in Iceland.
Additionally, Aztiq is a major shareholder in Þorpið (reads Thorpid) – an ecological community development project, in partnership with the City of Reykjavik.
The fund’s shareholder base consists of individual investors, led by Robert Wessman, as well as large international investment funds.